Paul Armentano, NORML Deputy Director

Paul Armentano, NORML Deputy Director

About Paul Armentano, NORML Deputy Director

This author has not yet filled in any details.
So far Paul Armentano, NORML Deputy Director has created 201 blog entries.

Review Paper: Clinical Evidence Lacking in Support of CBD as an Anti-Viral Agent

“Claims about the benefits of using CBD on viral infections were largely supported by CBD online retailers and most often appear to be a biased interpretation of the scientific literature or a dishonest manipulation of the information for commercial purposes.”

Poll: Majority of Americans Favor Designating Cannabis Dispensaries as “Essential Services”

A majority of Americans agree with states’ decisions to classify licensed medical cannabis facilities as “essential services” to the community – a designation that permits them to maintain retail operations during regional ‘stay-at-home’ orders.

NORML Says DEA’s Newly Proposed Bulk Cultivation Rules Are “Unduly Onerous, Expensive, and Impractical”

“These new rules are unduly onerous, expensive, and impractical. Even if they are ultimately implemented, it is unlikely that they would greatly facilitate clinical cannabis research in the United States.”